The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADC Therapeutics, Inc. Common H0036K147 2,658 334,384 SH   SOLE   334,384 0 0
Amicus Therapeutics Inc. Common 03152W109 5,323 495,603 SH   SOLE   495,603 0 0
Arcutis Biotherapeutics inc Common 03969K108 5,509 258,500 SH   SOLE   258,500 0 0
Avadel Pharmaceuticals Plc ADR 05337M104 1,006 412,363 SH   SOLE   412,363 0 0
AVROBIO, Inc. Common 05455M100 596 647,918 SH   SOLE   647,918 0 0
Biocryst Pharmaceuticals Inc. Common 09058V103 6,762 639,089 SH   SOLE   639,089 0 0
Black Diamond Therapeutics, Inc. Common 09203E105 590 239,888 SH   SOLE   239,888 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107 6,839 366,676 SH   SOLE   366,676 0 0
Cullinan Oncology, Inc. Common 230031106 98,051 7,648,268 SH   SOLE   7,648,268 0 0
Cytokinetics Inc. Common 23282W605 7,632 194,246 SH   SOLE   194,246 0 0
Epizyme, Inc. Common 29428V104 5,035 3,425,202 SH   SOLE   3,425,202 0 0
ESSA Pharma, Inc. Common 29668H708 2,082 660,892 SH   SOLE   660,892 0 0
G1 Therapeutics, Inc. Common 3621LQ109 4,233 856,798 SH   SOLE   856,798 0 0
Geron Corporation Common 374163103 13,074 8,434,991 SH   SOLE   8,434,991 0 0
Harmony Biosciences Hldgs Inc. Common 413197104 6,707 137,517 SH   SOLE   137,517 0 0
Harpoon Therapeutics, Inc. Common 41358P106 6,106 3,196,707 SH   SOLE   3,196,707 0 0
Inhibrx, Inc. Common 45720L107 11,615 1,023,325 SH   SOLE   1,023,325 0 0
Inozyme Pharma Inc. Common 45790W108 3,172 664,980 SH   SOLE   664,980 0 0
Intellia Therapeutics, Inc. Common 45826J105 15,497 299,409 SH   SOLE   299,409 0 0
Iovance Biotherapeutics Inc Com Common 462260100 13,248 1,200,000 SH   SOLE   1,200,000 0 0
iTeos Therapeutics, Inc. Common 46565G104 35,966 1,745,943 SH   SOLE   1,745,943 0 0
Karuna Therapeutics inc Common 48576A100 2,530 20,000 SH   SOLE   20,000 0 0
Madrigal Pharmaceuticals inc Common 558868105 3,221 45,000 SH   SOLE   45,000 0 0
Merus N.V. Common N5749R100 20,817 919,482 SH   SOLE   919,482 0 0
Mirum Pharmaceuticals Inc. Common 604749101 5,615 288,531 SH   SOLE   288,531 0 0
Neogenomics Inc. Common 64049M209 1,105 135,573 SH   SOLE   135,573 0 0
Oncorus, Inc. Common 68236R103 2,995 2,377,031 SH   SOLE   2,377,031 0 0
Phathom Pharmaceuticals inc Common 71722W107 1,632 193,326 SH   SOLE   193,326 0 0
Provention Bio Inc Common 74374N102 2,370 592,435 SH   SOLE   592,435 0 0
Reata Pharmaceuticals inc-a Common 75615P103 5,470 180,000 SH   SOLE   180,000 0 0
Repare Therapeutics, Inc. Common 760273102 22,941 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100 2,846 146,041 SH   SOLE   146,041 0 0
TCR2 Therapeutics, Inc. Common 87808K106 9,776 3,370,982 SH   SOLE   3,370,982 0 0
Travere Therapeutics Inc. Common 89422G107 6,735 277,950 SH   SOLE   277,950 0 0
Verastem, Inc. Common 92337C104 3,764 3,244,650 SH   SOLE   3,244,650 0 0
Werewolf Therapeutics, Inc. Common 95075A107 9,767 2,388,011 SH   SOLE   2,388,011 0 0
YmAbs Therapeutics, Inc. Common 984241109 6,713 443,702 SH   SOLE   443,702 0 0